Development of multi-cancer tests and studying early cancer biology
- Challenge: Developing novel diagnostic strategies
The award-winning suspected cancer (SCAN) pathway was developed in 2017 to accelerate cancer diagnosis in patients with non-specific but concerning symptoms of cancer. Initially deployed in Oxford, where patients undergo a full body low-dose Computed Tomography scan, blood, urine and stool tests resulting in 2-3 new cancer cases diagnosed each week, this innovate approach is now being rolled out nationally. Oxford Cancer infrastructure is enhancing the ability of this resource to allow early and peri-cancer biology studies across multiple disease sites and act as a test bed for integrating novel multi-parametric multi-cancer diagnostic platforms.